Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

British Journal of Haematology

Volumn 107, Issue 1, 1999, Pages 80-85

  Krauter, Jürgen ^a   Wattjes, Mike Peter ^a   Nagel, Stefan ^a   Heidenreich, Olaf ^b   Krug, Utz ^a   Kafert, Sabine ^a   Bunjes, Donald ^c   Bergmann, Lothar ^c   Ganser, Arnold ^a   Heil, Gerhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

AML; Chemotherapy; Karyotype; Minimal residual disease; RT PCR

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; LEUKEMOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0032708065     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01674.x     Document Type: Article

References (23)

1. Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carrol, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. & Mayer, R.J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research, 58, 4173-4179.
2. Desjardin, L.E., Chen, Y., Perkins, M.D., Teixeira, L., Cave, M.D. & Eisenach, K.D. (1998) Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis. Journal of Clinical Microbiology, 36, 1964-1968.
3. Fenaux, P., Lai, J.L., Preudhomme, C., Jouet, J.P., Deminatti, M. & Bauters, F. (1990) Is translocation (8:21) a 'favourable' cytogenetic rearrangement in acute myeloid leukaemia? Nouvelle Revue Française d'Hématologie, 32, 179-182.
4. Gerard, C.J., Olsson, K., Ramanathan, R., Reading, C. & Hanania, E.G. (1998) Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Research, 58, 3957-3964.
5. Gibson, U.E.M., Heid, C.A. & Williams, M.P. (1996) A novel method for real time quantitative RT-PCR. Genome Research, 6, 995-1001.
6. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood, 92, 2322-2333.
7. Heid, C.A., Stevens, J., Livak, K.J. & Williams, M.P. (1996) Real time quantitative PCR. Genome Research, 6, 986-994.
8. Heil, G., Krauter, J., Raghavachar, A., Hoelzer, D., Hossfeld, D., Mertelsmann, R., Noens, L., Schlimok, G., Port, M., Schwab, G. & Ganser, A. (1997) Risk-adapted induction and consolidation therapy including autologous peripheral blood stem cell transplantation (PBSCT) in adult de-novo AML patients. (Abstract). Blood 90, 508a.
9. Jurlander, J., Caligiuri, M.A., Ruutu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., Hoffmann, L., Ball, E.D., Frei Lahr, D.A., Christiansen, N.P., Block, A.M., Knuutila, S., Herzig, G.P. & Bloomfield, C.D. (1996) Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood, 88, 2183-2191.
10. Krauter, J., Peter, W., Pascheberg, U., Heinze, B., Bergmann, L., Hoelzer, D., Lübbert, M., Schlimok, G., Arnold, R., Kirchner, H., Port, M., Ganser, A. & Heil, G. (1998) Detection of karyotypic aberrations in acute myeloblastic leukemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. British Journal of Haematology, 103, 72-78.
11. Kusec, R., Laczika, K., Knobl, P., Friedl, J., Greinix, H., Kahls, P., Linkesch, W., Schwarzinger, I., Mitterbauer, G., Purtscher, B., Haas, O., Lechner, K. & Jaeger, K. (1994) AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia, 8, 735-739.
12. Marcucci, G., Livak, K.J., Bi, W., Strout, M.P., Bloomfield, C.D. & Caligiuri, M.A. (1998) Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia, 12, 1482-1489.
13. Mensink, E., van de Locht, A., Schattenberg, A., Linders, E., Schaap, N., Geurts van Kessel, A. & De Witte, T. (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia using real-time quantitative RT-PCR. British Journal of Haematology, 102, 768-774.
14. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., Dohy, H. & Niho, Y. (1996) Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood, 87, 4789-4796.
15. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. & Ohki, M. (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO Journal, 12, 2715-2721.
16. Muto, A., Mori, S., Matsushita, H., Awaya, N., Ueno, H., Takayama, N., Okamoto, S., Kizaki, M. & Ikeda, Y. (1996) Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay. British Journal of Haematology, 91 85-94.
17. Nason Burchenal, K., Gandini, D., Botto, M., Allopenna, J., Scale, J.R., Cross, N.C., Goldman, J.M., Dmitrovsky, E. & Pandolfi, P.P. (1996) Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Blood, 88, 3926-3936.
18. Nucifora, G., Larson, R.A. & Rowley, J.D. (1993) Persistence of the 8;21 translocation in patients with acute meyloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
19. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoicsis. Cell, 84, 321-330.
20. Pongers-Willemse, M.J., Verhagen, O.J., Tibbe, G.J., Wijkhuijs, A.J., de Haas, V., Roovers, E., van der Schoot, C.E. & van Dongen, J.J. (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using functional region specific TaqMan probes. Leukemia, 12, 2006-2014.
21. Seale, J.R., Varma, S., Swirsky, D.M., Pandolfi, P.P., Goldman, J.M. & Cross, N.C. (1996) Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon. British Journal of Haematology, 95, 95-101.
22. Shimizu, K., Miyoshi, H., Kozu, T., Nagata, J., Enomoto, K., Maseki, N., Kaneko, Y. & Ohki, M. (1992) Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Research, 52, 6945-6948.
23. Tobal, K. & Yin, J.A. (1996) Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21). Blood, 88, 3704-3709.